Actively Recruiting
Prospective Cohort With Hemopathy in Languedoc-Roussillon
Led by University Hospital, Montpellier · Updated on 2022-01-04
500
Participants Needed
1
Research Sites
1008 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.
CONDITIONS
Official Title
Prospective Cohort With Hemopathy in Languedoc-Roussillon
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18
- Consultant or hospitalized patient for suspected malignant hemopathy needing further tests or diagnosed with malignant hemopathy less than 6 months ago
- Signed informed consent
- Affiliated with a social security scheme
You will not qualify if you...
- Minor or legally protected individuals
- Patients who have already received treatment for hematological disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hematology department - UHMontpellier Saint éloi
Montpellier, France
Actively Recruiting
Research Team
V
Valerie ROUILLE
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here